Literature DB >> 16175459

Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Philipp Ströbel1, Alexander Marx, Andreas Zettl, Hans Konrad Müller-Hermelink.   

Abstract

When dealing with tumors of the thymus and mediastinum, both the surgeon and the pathologist are confronted with a vast variety of different pathohistologic entities, among which epithelial tumors, namely thymomas and thymic carcinomas, are the most frequent. Intimate knowledge of the different entities and their anticipated clinical outcome is required to meet diagnostic and therapeutic challenges. We herein briefly update the reader with the most important new changes in the 2004 WHO classification of tumors of the thymus and to important new trends in the treatment of some of these tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16175459     DOI: 10.1007/s00595-005-3047-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  77 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.

Authors:  S Suster; C A Moran
Journal:  Am J Surg Pathol       Date:  1996-12       Impact factor: 6.394

Review 3.  Monoclonal antibodies as effective therapeutic agents for solid tumors.

Authors:  Yuji Hinoda; Shigeru Sasaki; Tadao Ishida; Kohzoh Imai
Journal:  Cancer Sci       Date:  2004-08       Impact factor: 6.716

4.  Long-term outcome after multimodality treatment for stage III thymic tumors.

Authors:  Federico Venuta; Erino A Rendina; Flavia Longo; Tiziano De Giacomo; Marco Anile; Edoardo Mercadante; Luigi Ventura; Mattia F Osti; Federico Francioni; Giorgio F Coloni
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

Review 5.  Thymoma and thymic carcinoma: therapeutic approaches.

Authors:  Anupama Kurup; Patrick J Loehrer
Journal:  Clin Lung Cancer       Date:  2004-07       Impact factor: 4.785

6.  Ectopic intrathyroidal thymoma: a case report and review.

Authors:  Jason B Cohen; Megan Troxell; Christina S Kong; I Ross McDougall
Journal:  Thyroid       Date:  2003-03       Impact factor: 6.568

7.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

8.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

Authors:  Christopher A French; Isao Miyoshi; Ichiro Kubonishi; Holcombe E Grier; Antonio R Perez-Atayde; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

9.  KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.

Authors:  Chin-Chen Pan; Paul Chih-Hsueh Chen; Hung Chiang
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

10.  Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation.

Authors:  Sunil Singhal; Joseph B Shrager; David I Rosenthal; Virginia A LiVolsi; Larry R Kaiser
Journal:  Ann Thorac Surg       Date:  2003-11       Impact factor: 4.330

View more
  33 in total

1.  Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis.

Authors:  Se Hoon Kim; Im Suk Koh; Yang Ki Minn
Journal:  J Clin Neurol       Date:  2015-08-21       Impact factor: 3.077

2.  Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity.

Authors:  Matthias Felix Häfner; Falk Roeder; Florian Sterzing; David Krug; Stefan A Koerber; Jutta Kappes; Hans Hoffmann; Alla Slynko; Jürgen Debus; Marc Bischof
Journal:  Strahlenther Onkol       Date:  2014-08-26       Impact factor: 3.621

3.  Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).

Authors:  Lothar Veits; Gunhild Mechtersheimer; Christina Steger; Jens Freitag; Gregor Mikuz; Kurt W Schmid; Walter Hofmann; Peter Schirmacher; Arndt Hartmann; Ralf J Rieker
Journal:  Virchows Arch       Date:  2011-07-07       Impact factor: 4.064

4.  Thymectomy for thymoma and myasthenia gravis. A survey of current surgical practice in thymic disease amongst EACTS members.

Authors:  Marco Lucchi; Paul Van Schil; Ralph Schmid; Federico Rea; Franca Melfi; Kalliopi Athanassiadi; Marcin Zielinski; Tom Treasure
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-27

5.  Prognostic value of immunohistochemical markers in malignant thymic epithelial tumors.

Authors:  Priska Leisibach; Didier Schneiter; Alex Soltermann; Yoshi Yamada; Walter Weder; Wolfgang Jungraithmayr
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Risk stratification of thymic epithelial tumors by using a nomogram combined with radiomic features and TNM staging.

Authors:  Qijun Shen; Yanna Shan; Wen Xu; Guangzhu Hu; Wenhui Chen; Zhan Feng; Peipei Pang; Zhongxiang Ding; Wenli Cai
Journal:  Eur Radiol       Date:  2020-08-05       Impact factor: 5.315

7.  Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study.

Authors:  Seena C Aisner; Suzanne Dahlberg; Meera R Hameed; David S Ettinger; Joan H Schiller; David H Johnson; Joseph Aisner; Patrick J Loehrer
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

8.  AB thymoma with atypical type A component with delayed multiple lung and brain metastases.

Authors:  Wieslawa Grajkowska; Ewa Matyja; Jacek Kunicki; Sylwia Szymanska; Alexander Marx; Cleo-Aron Weis; Renata Langfort; Malgorzata Szolkowska
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

9.  Volume-based quantification using dual-energy computed tomography in the differentiation of thymic epithelial tumours: an initial experience.

Authors:  Suyon Chang; Jin Hur; Dong Jin Im; Young Joo Suh; Yoo Jin Hong; Hye-Jeong Lee; Young Jin Kim; Kyunghwa Han; Dae Joon Kim; Chang Young Lee; Ha Young Shin; Byoung Wook Choi
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

10.  Multimodality treatment of stage II thymic tumours.

Authors:  Carolina Carillo; Daniele Diso; Sara Mantovani; Ylenia Pecoraro; Tiziano De Giacomo; Anna Maria Ciccone; Camilla Poggi; Flavia Longo; Raffaele Cassese; Vincenzo Tombolini; Erino Angelo Rendina; Federico Venuta; Marco Anile
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.